IFOSFAMIDE (IFO) IN CONTINUOUS-INFUSION (CI) FOR 21 DAYS AS 2ND LINE THERAPY IN ADVANCED SARCOMAS - A PHASE-I STUDY

Citation
A. Comandone et al., IFOSFAMIDE (IFO) IN CONTINUOUS-INFUSION (CI) FOR 21 DAYS AS 2ND LINE THERAPY IN ADVANCED SARCOMAS - A PHASE-I STUDY, European journal of cancer, 33, 1997, pp. 499-499
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09598049
Volume
33
Year of publication
1997
Supplement
8
Pages
499 - 499
Database
ISI
SICI code
0959-8049(1997)33:<499:I(IC(F>2.0.ZU;2-4